Table 3.
Ordinal Logistic Regression Analysis Assessing the Association Between Baseline Characteristics, In‐Hospital Treatments, and Discharge Medications With Home‐Time Stratified Into Sextiles
| Variable | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| Proportional OR (95% CI) | P Value | Proportional OR (95% CI) | P Value | Proportional OR (95% CI) | P Value | |
| Demographics | ||||||
| Age | 0.97 (0.94–1.002) | 0.07 | 0.97 (0.95–1.002) | 0.07 | … | … |
| Diabetes mellitus | 0.36 (0.19–0.65) | <0.001 | 0.38 (0.20–0.71) | 0.003 | 0.42 (0.24–0.83) | 0.004 |
| COPD | 0.49 (0.26–0.93) | 0.03 | 0.48 (0.26–0.91) | 0.02 | 0.44 (0.24–0.83) | 0.01 |
| Hypertension | 1.67 (0.83–3.34) | 0.15 | … | … | … | … |
| Hyperlipidemia | 2.34 (1.28–4.35) | 0.006 | 2.48 (1.36–4.60) | 0.003 | 2.08 (1.16–3.78) | 0.01 |
| Prior PTCA or PCI | 0.48 (0.23–0.99) | 0.05 | 0.49 (0.23–1.04) | 0.06 | 0.44 (0.22–0.88) | 0.02 |
| History of malignancy | 0.56 (0.30–1.05) | 0.07 | … | … | 0.56 (0.30–1.05) | 0.07 |
| CKD | 0.54 (0.30–0.94) | 0.03 | 0.58 (0.33–1.03) | 0.06 | 0.56 (0.32–0.98) | 0.04 |
| Prior GI bleed | 0.31 (0.13–0.78) | 0.01 | 0.32 (0.13–0.80) | 0.01 | 0.36 (0.14–0.90) | 0.03 |
| Previous MI | … | … | 0.48 (0.24–0.96) | 0.04 | … | … |
| PAD | 0.63 (0.33–1.20) | 0.15 | … | … | … | … |
| TIMI score | 1.33 (1.03–1.73) | 0.03 | 1.25 (0.95–1.66) | 0.11 | … | … |
| GRACE score 110–140 | 1.28 (0.50–3.19) | 0.60 | 1.36 (0.53–3.45) | 0.51 | 1.23 (0.51–2.88) | 0.63 |
| GRACE score >140 | 0.50 (0.17–1.37) | 0.18 | 0.53 (0.18–1.44) | 0.22 | 0.33 (0.14–0.71) | 0.006 |
| In‐hospital treatment | ||||||
| Aspirin | … | … | 2.01 (1.00–4.02) | 0.05 | … | … |
| β‐blocker | … | … | 1.81 (0.99–3.31) | 0.05 | … | … |
| Discharge medications | ||||||
| Aspirin | … | … | … | … | 2.61 (1.36–5.01) | 0.004 |
| β‐blocker | … | … | … | … | 2.02 (1.08–3.80) | 0.03 |
| Deviation | 562.20 | 554.47 | 554.08 | |||
| AIC | 598.20 | 590.47 | 586.08 | |||
Models were structured hierarchically first including baseline patient characteristics (model 1), followed by addition of in‐hospital MI‐related treatments (model 2), and discharge medications (model 3). AIC, Akaike information criterion; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; GI, gastrointestinal; MI, myocardial infarction; OR, odds ratio; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; and PTCA, percutaneous transluminal coronary angioplasty.